MedPath

OPEN CLINICAL EVALUATION OF SIDDHA MEDICINE NAGA SANGU PARPAM IN KABAYONI ROGAM ( VULVO VAGINAL CANDIDIASIS

Phase 2
Conditions
Health Condition 1: N908- Other specified noninflammatory disorders of vulva and perineum
Registration Number
CTRI/2022/11/047334
Lead Sponsor
AMARAVATHY S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Females of age between 18 to 45 yrs patients with whitish discharge Vulvovaginal itching erosions inflammation and erythematous surface is covered by whitish coat Positive candida albicans Diabetes mellitus

Exclusion Criteria

Sexually Transmitted diseases (Gonorrhoea,Syphilis,HIV)

Non specific leucorrhoea

Pregnancy and lactation

Malignancy in uterus and Ovary

Vulvovaginosis caused by other organism

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome is assessed by reduction in clinical symptoms like pruritis of vulva vulvovaginal inflammation and curdy white discharge.Timepoint: One week
Secondary Outcome Measures
NameTimeMethod
Secondary outcome is mainly assessed by comparing the safety parameters before and after the treatmentTimepoint: 48 days
© Copyright 2025. All Rights Reserved by MedPath